Findok · Richtlinien
VB-0220
Anlage 3
überholte Fassung (bis 31.12.2011)RichtlinieBMF-010311/0077-IV/8/2011gilt ab 12.07.2011
Inhaltsverzeichnis der VB-0220
Überholte Fassung. Dieser Wortlaut galt vom 12.07.2011 bis 31.12.2011.
01.03.200701.02.200916.06.200924.12.200921.08.201011.11.201012.07.201101.01.201226.11.201201.01.201515.09.201501.05.201601.01.201731.10.201730.07.201919.05.202002.02.202115.07.202128.01.202322.01.202429.04.202420.01.202513.07.2026 (geltend)
Wortlaut laut Findok
Anlage 3
Liste der Suchtmittel, geordnet nach Positionen der Kombinierten Nomenklatur
Hinweis:
In der Spalte "Anlage" bedeuten:
Aes handelt sich um ein in den Anhängen I bis V der Suchtgiftverordnung (siehe Anlage 1) genanntes Suchtgift; der jeweilige Anhang der Suchtgiftverordnung wird durch den Zusatz "(Anhang I)", "(Anhang II)", "(Anhang III)", "(Anhang IV)" oder "(Anhang V)" angegeben;
Bes handelt sich um einen im Anhang der Psychotropenverordnung (siehe Anlage 2) genannten Stoff.
Warenkatalog:
|
KN-Code
|
Warenbezeichnung
|
Abschnitt
|
ex
|
0602 90 50
|
Hanfpflanzen
|
A (Anhang I) und Abschnitt 1.1.4.
|
ex
|
0604 91 90
|
Mohnstroh (Mohnkapseln)
|
Abschnitt 1.1.3.
|
|
|
Hanfpflanzen
|
A (Anhang I) und Abschnitt 1.1.4.
|
|
0604 99
|
Mohnstroh (Mohnkapseln)
|
Abschnitt 1.1.3.
|
|
|
Hanfpflanzen
|
A (Anhang I) und Abschnitt 1.1.4.
|
|
1211 30
|
Cocablätter
|
A (Anhang I)
|
ex
|
1211 90 98
|
Cannabis
|
A (Anhang I)
|
ex
|
1301 90 85
|
Cannabisharz (Haschisch)
|
A (Anhang I)
|
|
1302 11
|
Opium, Rohopium
|
A (Anhang I)
|
ex
|
1302 19 80
|
Cannabis-Extrakte und -Tinkturen
|
A (Anhang I)
|
|
|
Mohnstrohkonzentrat
|
A (Anhang I)
|
ex
|
1404 90
|
Mohnstroh (Mohnkapseln)
|
Abschnitt 1.1.3.
|
ex
|
2905 51
|
Ethchlorvynol
|
B (Anlage 2)
|
ex
|
2918 19 98
|
GHB (Gamma-Hydroxybutyrat-Acid)
|
B (Anlage 2)
|
|
2921 46
|
Amfetamin
|
A (Anhang IV)
|
|
|
Benzfetamin
|
B (Anlage 2)
|
|
|
Dexamphetamin
|
A (Anhang IV)
|
|
|
Etilamfetamin
|
B (Anlage 2)
|
|
|
Fencamfamin
|
B (Anlage 2)
|
|
|
Lefetamin
|
B (Anlage 2)
|
|
|
Levamfetamin
|
A (Anhang IV)
|
|
|
Mefenorex
|
B (Anlage 2)
|
|
|
Phentermin
|
B (Anlage 2)
|
ex
|
2921 49
|
Eticyclidin
|
A (Anhang V)
|
|
|
PCE
|
A (Anhang V)
|
|
2922 14
|
Dextropropoxyphen
|
A (Anhang II)
|
ex
|
2922 19 85
|
Acetylmethadol
|
A (Anhang I)
|
|
|
Alphacetylmethadol
|
A (Anhang I)
|
|
|
Alphamethadol
|
A (Anhang I)
|
|
|
Betacetylmethadol
|
A (Anhang I)
|
|
|
Betamethadol
|
A (Anhang I)
|
|
|
Dimenoxadol
|
A (Anhang I)
|
|
|
Dimepheptanol
|
A (Anhang I)
|
|
|
Levacetylmethadol
|
A (Anhang I)
|
|
|
Noracymethadol
|
A (Anhang I)
|
ex
|
2922 29
|
Brolamfetamin
|
A (Anhang V)
|
|
|
DOB
|
A (Anhang V)
|
|
|
DOET
|
A (Anhang V)
|
|
|
DOM
|
A (Anhang V)
|
|
|
STP
|
A (Anhang V)
|
|
|
DMA
|
A (Anhang V)
|
|
|
PMA
|
A (Anhang V)
|
|
|
TMA
|
A (Anhang V)
|
|
|
TMA-2 (2,3,4-Trimethoxyamphetamin)
|
A (Anhang V)
|
|
|
2C-I (4-Iod-2,5-dimethoxyphenylethylamin)
|
A (Anhang V)
|
|
2922 31
|
Amfepramon
|
B (Anlage 2)
|
|
|
Methadon, einschließlich Isomethadon und Levo-(R(-)) Methadon (Polamidon)
|
A (Anhang I)
|
|
|
Normethadon
|
A (Anhang I)
|
|
2922 44
|
Tilidin
|
A (Anhang I)
|
ex
|
2922 50
|
Tramadol
|
A (Anhang IV)
|
|
2924 11
|
Meprobamat
|
B (Anlage 2)
|
ex
|
2924 24
|
Ethinamat
|
B (Anlage 2)
|
ex
|
2924 29 98
|
Diampromid
|
A (Anhang I)
|
|
2925 12
|
Glutethimid
|
B (Anlage 2)
|
|
2926 30
|
Methadon-Zwischenprodukt
|
A (Anhang I)
|
|
|
Fenproporex
|
B (Anlage 2)
|
ex
|
2930 90 99
|
4-MTA
|
A (Anhang V)
|
ex
|
2932 99
|
Delta-9-Tetrahydrocannabinol und deren stereochemischen Varianten
|
A (Anhang IV)
|
|
2932 95
|
Tetrahydrocannabinole (=THCA) und die im Anhang V
angeführten Isomere
|
A (Anhang V)
|
ex
|
2932 99
|
Delta-9-Tetrahydrocannabinol und deren stereochemischen Varianten
|
A (Anhang IV)
|
|
|
MBDB
|
A (Anhang V)
|
|
|
MDA
|
A (Anhang V)
|
|
|
MDE
|
A (Anhang V)
|
|
|
MDMA
|
A (Anhang V)
|
|
|
N-Äthyl MDA
|
A (Anhang V)
|
|
|
Tenamfetamin
|
A (Anhang V)
|
|
|
DMHP
|
A (Anhang V)
|
|
|
MMDA
|
A (Anhang V)
|
|
|
N-Hydroxy MDA
|
A (Anhang V)
|
|
|
Parahexyl
|
A (Anhang V)
|
ex
|
2933 33
|
Alfentanil
|
A (Anhang I)
|
|
|
Anileridin
|
A (Anhang I)
|
|
|
Bezitramid
|
A (Anhang I)
|
|
|
Bromazepam
|
B (Anlage 2)
|
|
|
Difenoxin
|
A (Anhang I)
|
|
|
Diphenoxylat
|
A (Anhang I)
|
|
|
Dipipanon
|
A (Anhang I)
|
|
|
Fentanyl
|
A (Anhang I)
|
|
|
Ketobemidon
|
A (Anhang I)
|
|
|
Methylphenidat
|
A (Anhang IV)
|
|
|
Pentazocin
|
A (Anhang IV)
|
|
|
Pethidin
|
A (Anhang I)
|
|
|
Pethidin-Zwischenprodukt A
|
A (Anhang I)
|
|
|
Phencyclidin
|
A (Anhang IV)
|
|
|
Phenoperidin
|
A (Anhang I)
|
|
|
Pipradol
|
B (Anlage 2)
|
|
|
Piritramid
|
A (Anhang I)
|
|
|
Propiram
|
A (Anhang II)
|
|
|
Trimeperidin
|
A (Anhang I)
|
ex
|
2933 39 99
|
Acetyl-alpha-methylfentanyl
|
A (Anhang I)
|
|
|
Allylprodin
|
A (Anhang I)
|
|
|
Alpha-methylfentanyl
|
A (Anhang I)
|
|
|
Alphameprodin
|
A (Anhang I)
|
|
|
Alphaprodin
|
A (Anhang I)
|
|
|
Benzethidin
|
A (Anhang I)
|
|
|
Beta-hydroxy-3-methylfentanyl
|
A (Anhang I)
|
|
|
Beta-hydroxyfentanyl
|
A (Anhang I)
|
|
|
Betameprodin
|
A (Anhang I)
|
|
|
Betaprodin
|
A (Anhang I)
|
|
|
Etoxeridin
|
A (Anhang I)
|
|
|
Hydroxypethidin
|
A (Anhang I)
|
|
|
Metazocin
|
A (Anhang I)
|
|
|
3-Methylfentanyl
|
A (Anhang I)
|
|
|
MPPP
|
A (Anhang I)
|
|
|
Norpipanon
|
A (Anhang I)
|
|
|
Para-fluorofentanyl
|
A (Anhang I)
|
|
|
PEPAP
|
A (Anhang I)
|
|
|
Pethidin-Zwischenprodukt B
|
A (Anhang I)
|
|
|
Pethidin-Zwischenprodukt C
|
A (Anhang I)
|
|
|
Phenampromid
|
A (Anhang I)
|
|
|
Phenazocin
|
A (Anhang I)
|
|
|
Piminodin
|
A (Anhang I)
|
|
|
Properidin
|
A (Anhang I)
|
|
|
Remifentanil
|
A (Anhang I)
|
|
2933 41
|
Levorphanol
|
A (Anhang I)
|
ex
|
2933 49 90
|
Drotebanol
|
A (Anhang I)
|
|
|
Levomethorphan, ausgenommen Dextromethorphan
|
A (Anhang I)
|
|
|
Levophenacylmorphan
|
A (Anhang I)
|
|
|
Norlevorphanol
|
A (Anhang I)
|
|
|
Phenomorphan
|
A (Anhang I)
|
|
|
Phenomorphan
|
A (Anhang I)
|
|
|
Racemethorphan
|
A (Anhang I)
|
|
|
Racemorphan
|
A (Anhang I)
|
|
2933 53
|
Amobarbital
|
B (Anlage 2)
|
|
|
Barbital
|
B (Anlage 2)
|
|
|
Phenobarbital
|
B (Anlage 2)
|
|
|
Allobarbital
|
B (Anlage 2)
|
|
|
Butalbital
|
B (Anlage 2)
|
|
|
Butobarbital
|
B (Anlage 2)
|
|
|
Cyclobarbital
|
B (Anlage 2)
|
|
|
Methylphenobarbital
|
B (Anlage 2)
|
|
|
Pentobarbital
|
B (Anlage 2)
|
|
|
Secbutabarbital
|
B (Anlage 2)
|
|
|
Secobarbital
|
A (Anhang IV)
|
|
|
Vinylbital
|
B (Anlage 2)
|
|
2933 55
|
Loprazolam
|
B (Anlage 2)
|
|
|
Mecloqualon
|
A (Anhang IV)
|
|
|
Methaqualon
|
A (Anhang IV)
|
|
|
Zipeprol
|
A (Anhang IV)
|
ex
|
2933 59 95
|
Benzylpiperazin (BZP)
|
A (Anhang V)
|
|
2933 72
|
Clobazam
|
B (Anlage 2)
|
|
|
Methyprylon
|
B (Anlage 2)
|
ex
|
2933 99 80
|
Etonitazen
|
A (Anhang I)
|
|
|
Clonitazen
|
A (Anhang I)
|
|
|
PCPY
|
A (Anhang V)
|
|
|
PHP
|
A (Anhang V)
|
|
|
Proheptazin
|
A (Anhang I)
|
|
|
Rolicyclidin
|
A (Anhang V)
|
|
|
Etryptamin
|
A (Anhang V)
|
|
|
Zolpidem
|
B (Anlage 2)
|
ex
|
2933 91
|
Alprazolam
|
B (Anlage 2)
|
|
|
Camazepam
|
B (Anlage 2)
|
|
|
Clonazepam
|
B (Anlage 2)
|
|
|
Diazepam
|
B (Anlage 2)
|
|
|
Estazolam
|
B (Anlage 2)
|
|
|
Ethylloflazepate
|
B (Anlage 2)
|
|
|
Fludiazepam
|
B (Anlage 2)
|
|
|
Flunitrazepam
|
B (Anlage 2)
|
|
|
Flurazepam
|
B (Anlage 2)
|
|
|
Halazepam
|
B (Anlage 2)
|
|
|
Lorazepam
|
B (Anlage 2)
|
|
|
Lormetazepam
|
B (Anlage 2)
|
|
|
Medazepam
|
B (Anlage 2)
|
|
|
Midazolam
|
B (Anlage 2)
|
|
|
Nimetazepam
|
B (Anlage 2)
|
|
|
Nitrazepam
|
B (Anlage 2)
|
|
|
Nordazepam
|
B (Anlage 2)
|
|
|
Oxazepam
|
B (Anlage 2)
|
|
|
Pinazepam
|
B (Anlage 2)
|
|
|
Prazepam
|
B (Anlage 2)
|
|
|
Temazepam
|
B (Anlage 2)
|
|
|
Tetrazepam
|
B (Anlage 2)
|
|
|
Triazolam
|
B (Anlage 2)
|
|
|
Chlordiazepoxid
|
B (Anlage 2)
|
|
|
Clorazepat
|
B (Anlage 2)
|
|
|
Delorazepam
|
B (Anlage 2)
|
|
|
Mazindol
|
B (Anlage 2)
|
|
|
Pyrovaleron
|
B (Anlage 2)
|
ex
|
2933 99 80
|
Etonitazen
|
A (Anhang I)
|
|
|
Clonitazen
|
A (Anhang I)
|
|
|
PCPY
|
A (Anhang V)
|
|
|
PHP
|
A (Anhang V)
|
|
|
Proheptazin
|
A (Anhang I)
|
|
|
Rolicyclidin
|
A (Anhang V)
|
|
|
Etryptamin
|
A (Anhang V)
|
|
|
Zolpidem
|
B (Anlage 2)
|
|
2934 91
|
Aminorex
|
B (Anlage 2)
|
|
|
Brotizolam
|
B (Anlage 2)
|
|
|
Clotiazepam
|
B (Anlage 2)
|
|
|
Cloxazolam
|
B (Anlage 2)
|
|
|
Dextromoramid
|
A (Anhang I)
|
|
|
Haloxazolam
|
B (Anlage 2)
|
|
|
Ketazolam
|
B (Anlage 2)
|
|
|
Mesocarb
|
B (Anlage 2)
|
|
|
Oxazolam
|
B (Anlage 2)
|
|
|
Pemolin
|
B (Anlage 2)
|
|
2934 99 90
|
Alpha-methylthiofentanyl
|
A (Anhang I)
|
|
|
3-Methylthiofentanyl
|
A (Anhang I)
|
|
2934 99 90
|
Diethylthiambuten
|
A (Anhang I)
|
|
|
Dimethylthiambuten
|
A (Anhang I)
|
|
|
Dioxaphetylbutyrat
|
A (Anhang I)
|
|
|
Ethylmethylthiambuten
|
A (Anhang I)
|
|
|
Furethidin
|
A (Anhang I)
|
|
|
Levomoramid
|
A (Anhang I)
|
|
|
4-Methylaminorex
|
A (Anhang V)
|
|
|
Moramid-Zwischenprodukt
|
A (Anhang I)
|
|
|
Morpheridin
|
A (Anhang I)
|
|
|
Phenadoxon
|
A (Anhang I)
|
|
|
Racemoramid
|
A (Anhang I)
|
|
|
Tenocyclidin (=TCP)
|
A (Anhang V)
|
|
|
2-C-T-2 (2,5-Dimethoxy-4-ethylthiophenylethylamin)
|
A (Anhang V)
|
|
|
2-C-T-7 (2,5-Dimethoxy-4(n)-propylthiophenylethylamin)
|
A (Anhang V)
|
|
2934 91
|
Aminorex
|
B (Anlage 2)
|
|
|
Brotizolam
|
B (Anlage 2)
|
|
|
Clotiazepam
|
B (Anlage 2)
|
|
|
Cloxazolam
|
B (Anlage 2)
|
|
|
Dextromoramid
|
A (Anhang I)
|
|
|
Haloxazolam
|
B (Anlage 2)
|
|
|
Ketazolam
|
B (Anlage 2)
|
|
|
Mesocarb
|
B (Anlage 2)
|
|
|
Oxazolam
|
B (Anlage 2)
|
|
|
Pemolin
|
B (Anlage 2)
|
|
|
Phendimetrazin
|
B (Anlage 2)
|
|
|
Phenmetrazin
|
A (Anhang IV)
|
|
|
Sufentanil
|
A (Anhang I)
|
ex
|
2934 99
|
Alpha-methylthiofentanyl
|
A (Anhang I)
|
|
|
3-Methylthiofentanyl
|
A (Anhang I)
|
|
2939 11
|
Buprenorphin
|
A (Anhang IV)
|
|
|
Codein
|
A (Anhang II)
|
|
|
Diacetylmorphin (Heroin)
|
A (Anhang I)
|
|
|
Dihydrocodein
|
A (Anhang II)
|
|
|
Ethylmorphin (Äthylmorphin)
|
A (Anhang II)
|
|
|
Etorphin
|
A (Anhang I)
|
|
|
Heroin, Diacetylmorphin
|
A (Anhang I)
|
|
|
Hydrocodon
|
A (Anhang I)
|
|
|
Hydromorphon
|
A (Anhang I)
|
|
|
Mohnstrohkonzentrat
|
A (Anhang I)
|
|
|
Morphin
|
A (Anhang I)
|
|
|
Nicomorphin
|
A (Anhang I)
|
|
|
Oxycodon
|
A (Anhang I)
|
|
|
Oxymorphon
|
A (Anhang I)
|
|
|
Pholcodin
|
A (Anhang II)
|
|
|
Thebacon
|
A (Anhang I)
|
|
|
Thebain
|
A (Anhang I)
|
ex
|
2939 19
|
Acetorphin
|
A (Anhang I)
|
|
|
Acetyldihydrocodein
|
A (Anhang II
|
|
|
Benzylmorphin
|
A (Anhang I)
|
|
|
Codein-N-oxid
|
A (Anhang I)
|
|
|
Codoxim
|
A (Anhang I)
|
|
|
Desomorphin
|
A (Anhang I)
|
|
|
Dihydromorphin
|
A (Anhang I)
|
|
|
Hydromorphinol
|
A (Anhang I)
|
|
|
Methyldesorphin
|
A (Anhang I)
|
|
|
Methyldihydromorphin
|
A (Anhang I)
|
|
|
Metopon
|
A (Anhang I)
|
|
|
Monoacetylmorphin, 6-Acetyl-Morphin
|
A (Anhang I)
|
|
|
Morphinmethobromid und andere quartäre Salze des Morphins
|
A (Anhang I)
|
|
|
Morphin-N-oxid
|
A (Anhang I)
|
|
|
Myrophin
|
A (Anhang I)
|
|
|
Nicocodin
|
A (Anhang II
|
|
|
Nicodicodin
|
A (Anhang II
|
|
|
Norcodein
|
A (Anhang II
|
|
|
Normorphin
|
A (Anhang I)
|
|
|
Oripavin
|
A (Anhang I)
|
|
2939 43
|
Cathin
|
B (Anlage 2)
|
ex
|
2939 49
|
(+)-Norpseudoephedrin
|
B (Anlage 2)
|
|
2939 51
|
Fenetyllin
|
A (Anhang IV)
|
ex
|
2939 69
|
LSD, LSD-25, (+)-Lysergid
|
A (Anhang V)
|
ex
|
2939 90 90
|
Mescalin
|
A (Anhang V)
|
|
|
Psilocybin
|
A (Anhang V)
|
ex
|
2939 91
|
Levomethamphetamin
|
A (Anhang IV)
|
|
|
Cocain
|
A (Anhang I)
|
|
|
Ecgonin
|
A (Anhang I)
|
|
|
Metamphetamin-Razemat
|
A (Anhang IV)
|
|
|
Methamphetamin
|
A (Anhang IV)
|
|
|
PMMA (Anhang Anhang Paramethoxymethamphetamin)
|
A (Anhang V)
|
ex
|
2939 99
|
2C-B (4-Bromo-2,5 dimethoxyphenethylamin)
|
A (Anhang V)
|
|
|
Cathinon
|
A (Anhang V)
|
|
|
DET
|
A (Anhang V)
|
|
|
DMT
|
A (Anhang V)
|
|
|
Mescalin
|
A (Anhang V)
|
|
|
Methcathinon
|
A (Anhang V)
|
|
|
4-Methyl-Methcathinon ("Mephedron")
|
A (Anhang V)
|
|
|
Psilocin, Psilotin
|
A (Anhang V)
|
|
|
Psilocybin
|
A (Anhang V)
|
|
|
Thiofentanyl
|
A (Anhang I)
|
ex
|
3001
|
Waren dieser Position, sofern sie Suchtmittel enthalten
|
A (Anlage 1, Anhang
I - V),
B (Anlage 2)
|
ex
|
3002
|
Waren dieser Position, sofern sie Suchtmittel enthalten
|
A (Anlage 1, Anhang
I - V),
B (Anlage 2)
|
ex
|
3003
|
Waren dieser Position, sofern sie Suchtmittel enthalten
|
A (Anlage 1, Anhang
I - V),
B (Anlage 2)
|
ex
|
3004
|
Waren dieser Position, sofern sie Suchtmittel enthalten
|
A (Anlage 1, Anhang
I - V),
B (Anlage 2)
|
|
5302 10
|
Hanfpflanzen
|
A (Anhang I) und Abschnitt 1.1.4.
Herkunft
Herkunft dieses Textes
- Bestand
- Richtlinien
- Dokumenttyp
- Richtlinie
- Geschäftszahl
- BMF-010311/0077-IV/8/2011
- GZ der Erstfassung
- BMF-010311/0020-IV/8/2007
- Stammnummer
- 27030
- Enthalten in Fassung
- 7 (geltend: 24)
- Gültig
- 12.07.2011 bis 31.12.2011
- Stand Bestandsliste
- 25.09.2026 06:11
- Von uns abgerufen
- 26.09.2026
- Quelle
- Findok – Finanzdokumentation des Bundesministeriums für Finanzen
- Lizenz
- CC0 1.0 — gemeinfrei gewidmet vom BMF